Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Enhanced chickenpox exanthema in vaccine injection site.

Hentgen V, Cohen R, Siegrist CA.

Scand J Infect Dis. 2006;38(10):920-1.

PMID:
17008239
2.

Simultaneous vaccination of Chinese applicants for a United States immigrant visa.

Hua L, Hongtao H, Shunqin W, Jinping G, Jiandong C, Zhaoliang L, Xinwen F.

Travel Med Infect Dis. 2008 May;6(3):130-6. doi: 10.1016/j.tmaid.2008.03.004.

PMID:
18486068
3.
5.

Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.

Ciarlet M, He S, Lai S, Petrecz M, Yuan G, Liu GF, Mikviman E, Heaton PM, Panzer F, Rose T, Koller DY, Van Damme P, Schödel F.

Pediatr Infect Dis J. 2009 Mar;28(3):177-81. doi: 10.1097/INF.0b013e31818c0161.

PMID:
19209092
6.

A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.

Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI.

Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977.

PMID:
19047220
7.
8.

Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children.

Halperin SA, Langley JM, Hesley TM, Zappacosta PS, Radley D, Smith B, Hoffenbach A, Boslego J, Silber JL.

Hum Vaccin. 2005 Nov-Dec;1(6):245-50. Epub 2005 Nov 17.

PMID:
17012871
9.

Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.

Zepp F, Knuf M, Habermehl P, Mannhardt-Laakmann W, Howe B, Friedland LR.

J Pediatr. 2006 Nov;149(5):603-610.

PMID:
17095328
10.
11.

Persistence of antibodies in children primed with two different hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type B vaccines and evaluation of booster vaccination.

Tichmann I, Grunert D, Habash S, Preidel H, Schult R, Pfletschinger U, Gildberg PK, Meurice F, Sänger R.

Hum Vaccin. 2006 Nov-Dec;2(6):249-54. Epub 2006 Nov 27.

PMID:
17106268
12.

Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.

Thisyakorn U, Pancharoen C, Chuenkitmongkol S, Ortiz E.

Southeast Asian J Trop Med Public Health. 2009 Mar;40(2):282-94.

PMID:
19323013
13.
16.

Safety and immunogenicity of a pentavalent combination vaccine (diphtheria, tetanus, acellular pertussis, polio, and haemophilus influenzae type B conjugate) when administered as a fourth dose at 15 to 18 months of age.

Scheifele DW, Halperin SA, Rubin E, Tapiero B, Guasparini R, Meekison W, Predy G, Mills E, Noriega F.

Hum Vaccin. 2005 Sep-Oct;1(5):180-6. Epub 2005 Sep 29.

PMID:
17012882
17.

Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination.

Jackson LA, Starkovich P, Dunstan M, Yu O, Nelson J, Dunn J, Rees T, Zavitkovsky A, Maus D, Froeschle JE, Decker M.

Pediatrics. 2008 Mar;121(3):e646-52. doi: 10.1542/peds.2007-1653.

PMID:
18310184
18.

Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study.

Carbone T, McEntire B, Kissin D, Kelly D, Steinschneider A, Violaris K, Karamchandani N.

Pediatrics. 2008 May;121(5):e1085-90. doi: 10.1542/peds.2007-2059.

PMID:
18450851
19.

Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.

Halperin SA, Tapiero B, Diaz-Mitoma F, Law BJ, Hoffenbach A, Zappacosta PS, Radley D, McCarson BJ, Martin JC, Brackett LE, Boslego JW, Hesley TM, Bhuyan PK, Silber JL.

Vaccine. 2009 Apr 28;27(19):2540-7. doi: 10.1016/j.vaccine.2008.11.115. Epub 2009 Jan 3.

PMID:
19124057
20.
Items per page

Supplemental Content

Write to the Help Desk